BAXTER HEALTHCARE CORPORATION v. HQ SPECIALTY PHARMA CORPORATION
1:13-cv-06228
Overview
Parties
Defendant
Ms. Janet Fenning-Owoo NPE (Individual / Inventor)
Represented By
1 Attorneys ListedDAVIDSON DAVIDSON & KAPPEL LLC
DAVIDSON DAVIDSON & KAPPEL LLC, 589 8th Avenue
Estate of George Owoo Operating Company
Represented By
1 Attorneys ListedDAVIDSON DAVIDSON & KAPPEL LLC
DAVIDSON DAVIDSON & KAPPEL LLC, 589 8th Avenue
Welgrace Research Group Operating Company
Represented By
1 Attorneys ListedDAVIDSON DAVIDSON & KAPPEL LLC
DAVIDSON DAVIDSON & KAPPEL LLC, 589 8th Avenue
HQ SPECIALTY PHARMA CORPORATION Operating Company
Represented By
4 Attorneys ListedGREENBERG, DAUBER, EPSTEIN & TUCKER, PC
ONE GATEWAY CENTER, SUITE 600
SAIBER LLC
SAIBER LLC, ONE GATEWAY CENTER
SAIBER LLC
SAIBER LLC, ONE GATEWAY CENTER
BAXTER INTERNATIONAL INC. Operating Company
Represented By
5 Attorneys ListedLaw Office of Thomas Lihan LLC
1224 Livingston Avenue, North Brunswick, NJ 08902
DECHERT LLP
Cira Centre, 2929 Arch Street
Plaintiff
BAXTER HEALTHCARE S.A. NPE (Individual / Inventor)
Represented By
5 Attorneys ListedLaw Office of Thomas Lihan LLC
1224 Livingston Avenue, North Brunswick, NJ 08902
DECHERT LLP
Cira Centre, 2929 Arch Street
Intervenor
BAXTER HEALTHCARE CORPORATION NPE (Individual / Inventor)
Represented By
5 Attorneys ListedLaw Office of Thomas Lihan LLC
1224 Livingston Avenue, North Brunswick, NJ 08902
DECHERT LLP
Cira Centre, 2929 Arch Street
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 22 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6310094
Ready-to-use esmolol solution
|
Filed: 2001-01-12
Issued: 2001-10-30
|
Expired (Term Ended)
Expires: 2021-01-12
|
|
|
US6528540
Esmolol formulation
|
Filed: 2001-10-30
Issued: 2003-03-04
|
Expired (Term Ended)
Expires: 2021-10-30
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
115
Dispositive
81
Granted
9
Denied
0
Pending / Review
71
Motions by Category
Key Dispositive Motions & Rulings